Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies
Open Access
- 8 August 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (43) , 75411-75417
Abstract
Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studiesKeywords
This publication has 27 references indexed in Scilit:
- Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based studyInternational Journal of Cancer, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With RosuvastatinJACC, 2011
- Immune Phenotype Predicts Risk for Posttransplantation Squamous Cell CarcinomaJournal of the American Society of Nephrology, 2010
- Incidence of cancer and statin usage—Record linkage studyInternational Journal of Cancer, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- Statins and cancer: A systematic review and meta-analysisEuropean Journal of Cancer, 2008
- Fluvastatin treatment is not associated with an increased incidence of cancerInternational Journal Of Clinical Practice, 2006
- Cancer risk among statin users: A population‐based cohort studyInternational Journal of Cancer, 2004
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994